학술논문

First-line gemcitabine versus epirubicin in postmenopausal women aged 60 or older with metastatic breast cancer: a multicenter, randomized, phase III study
Document Type
Article
Source
In Annals of Oncology June 2005 16(6):899-908
Subject
Language
ISSN
0923-7534